Health
FDA approves clinical trials to test the safety of cancer-detection technology – News-Medical.Net
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University:…
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.
The molecular-targeted imaging agent is licensed to Molecular Theranostics LLC, a Cleveland based startup company, and its partners U.S. Motek LLC and Jiangsu Motek Pharmaceuticals Ltd. of China.
The agent…
-
General21 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General7 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General19 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News22 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’